Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2012
12/19/2012CN102824355A Use of panax japonicus saponin IV a in preparation of alpha-glycosidase inhibitor
12/19/2012CN102824348A New technology for extracting sterol from corn germ oil deodorization distillate
12/19/2012CN102824338A Application of s-oleylpropanolamide in preparing medicine for reducing blood fat and preventing and treating non-alcoholic fatty liver
12/19/2012CN102824328A Collagen effervescent tablet
12/19/2012CN102824324A Glipizide sustained release tablets
12/19/2012CN102824322A Aliphatic amine polymer salts for tableting
12/19/2012CN102824320A Phytosterol tablet and preparation method thereof
12/19/2012CN102824315A Preparation method of vitamin C micro-pill
12/19/2012CN102824313A Vitamin C effervescent granule and preparation method thereof
12/19/2012CN102823873A Application of xanthoceras sorbifolia flavone to field of skin whitening and preparation method of xanthoceras sorbifolia flavone
12/19/2012CN102823866A Dietetic therapy product of sea-buckthorn lotus leaf juice for conditioning blood fat, reducing blood viscosity and improving myocardial blood
12/19/2012CN102823859A Composition comprising medlar, chrysanthemum or honeysuckle and calcium gluconate
12/19/2012CN102823792A Soft propolis astragalus mongholicus capsule and preparation method thereof
12/19/2012CN102823672A Puerh tea compound for controlling blood lipid
12/19/2012CN102379892B Blood lipid regulation, antiatherosclerotic and anti-myocardial ischemia functions of clematichinenoside
12/19/2012CN102260262B Method for purifying entecavir and tablets
12/19/2012CN102180985B Method for extracting and purifying mugwort polysaccharides
12/19/2012CN102085227B Preparation with function of reducing blood sugar and preparation method thereof
12/19/2012CN101926788B Cardiovascular/cerebral and ophthalmological medicines, and preparation and use thereof
12/19/2012CN101481338B Synthesizing method and use of vanadium taurate
12/19/2012CN101380358B Perilla frutescens seed oil fat emulsion injection and preparation process
12/19/2012CN101336705B Health food and its preparation method
12/19/2012CN101242858B Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
12/19/2012CN101229305B Process for fabricating hypoglycemic capsule
12/18/2012US8334260 sFRP and peptide motifs that interact with sFRP and methods of their use
12/18/2012CA2734231C Herbal supplement prepared from geranium
12/18/2012CA2719721C Tetrahydroisoquinoline derivative
12/18/2012CA2677572C 3-amino-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives as pkc inhibitors
12/18/2012CA2407895C Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
12/18/2012CA2392545C Pharmaceutical formulations for thyroid hormones
12/18/2012CA2363486C Compositions and methods for effecting the levels of high density lipoprotein (hdl) cholesterol and apolipoprotein ai, very low density lipoprotein (vldl) cholesterol and low density lipoprotein (ldl) cholesterol
12/13/2012WO2012170899A2 Pharmaceutical compositions containing proteases and methods for the treatment of lysosomal storage diseases
12/13/2012WO2012170867A1 Novel compounds as modulators of gpr-119
12/13/2012WO2012170702A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
12/13/2012WO2012170607A2 Use of pcsk9 antagonists
12/13/2012WO2012169897A1 Weight reducing material
12/13/2012WO2012169863A2 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof
12/13/2012WO2012169798A2 Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
12/13/2012WO2012169690A1 Ginsenoside boosting method
12/13/2012WO2012169661A1 Monatin polyvalent metal salt crystal
12/13/2012WO2012169654A1 Carbon-monoxide(co)-assisted inhibition of fatty acid and cholesterol uptake
12/13/2012WO2012169600A1 Amino acid composition
12/13/2012WO2012169579A1 Heterocyclic carboxylic acid ester derivative
12/13/2012WO2012169571A1 Novel n-(pyridin-2-yl)alkanamide derivative and ship2 inhibitor containing same as an active ingredient
12/13/2012WO2012168854A1 Synergistic combination for the treatment of type 2 diabetes mellitus
12/13/2012WO2012168665A1 Novel agomelatine cocrystals, method for preparing same, and pharmaceutical compositions containing same
12/13/2012WO2012168491A1 Pharmaceutical formulations of pcsk9 antagonists
12/13/2012WO2012168474A1 Novel methods
12/13/2012WO2012168315A1 Substituted piperidines as gpr119 modulators for the treatment of metabolic disorders
12/13/2012WO2012167744A1 Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof
12/13/2012WO2012167617A1 β INHIBITING PROTEIN 1, FRAGMENTS THEREOF, AND USE THEREOF
12/13/2012WO2012167370A1 Methods of phosvitin extraction and phosphopeptide preparation from egg yolk
12/13/2012WO2012105816A3 Composition for preventing and treating diabetes and diabetes complications comprising amphicarpaea edgeworthii var. trisperma powder or an extract thereof
12/13/2012WO2011156554A8 Cyclohexyl-azetidinyl antagonists of ccr2
12/13/2012US20120316380 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316249 Lycopene for the treatment for metabolic dysfunction
12/13/2012US20120316245 Co-crystals of agomelatine, a process for there preparation and pharmaceutical compositions containing them
12/13/2012US20120316242 Methods of treating metabolic disorders
12/13/2012US20120316233 Crystalline Solids of a METAP-2 Inhibitor and Methods of Making and Using Same
12/13/2012US20120316223 MODULATION OF pre-mRNA USING SPLICE MODULATING OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS IN THE TREATMENT OF DISEASE
12/13/2012US20120316219 Modulation of apolipoprotein(a) expression
12/13/2012US20120316215 Compositions and methods for treating metabolic disorders
12/13/2012US20120316214 Synthesis process, and crystalline form of 4-benzamide hydrochloride and pharmaceutical compositions containing it
12/13/2012US20120316212 Amino alcohol derivatives and their therapeutic activities
12/13/2012US20120316201 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/13/2012US20120316200 Pyridone derivatives
12/13/2012US20120316195 Aryl-pyridine derivatives as aldosterone synthase inhibitors
12/13/2012US20120316194 Apoptosis signal-regulating kinase 1 inhibitors
12/13/2012US20120316193 Proteostasis regulators
12/13/2012US20120316188 Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors
12/13/2012US20120316186 Deazapurines useful as inhibitors of janus kinases
12/13/2012US20120316182 Compounds that modulate intracellular calcium
12/13/2012US20120316180 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/13/2012US20120316179 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/13/2012US20120316175 Solid state forms of sitagliptin salts
12/13/2012US20120316172 Pyrazole derivatives
12/13/2012US20120316168 Quinolone compound and pharmaceutical composition
12/13/2012US20120316165 Substituted benzamide derivatives
12/13/2012US20120316163 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316156 [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid
12/13/2012US20120316155 Imidazole-2,4-Dione Inhibitors of Casein Kinase 1
12/13/2012US20120316152 Substituted isoquinolineand isoquinolinone derivatives
12/13/2012US20120316138 Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseases
12/13/2012US20120316123 Dietary supplement composition of citrus derivatives
12/13/2012US20120316122 Pharmaceutical compositions for combating thrombotic diseases and their preparation and uses
12/13/2012US20120316121 Materials and Methods for Modulating Arginine Metabolism
12/13/2012US20120316108 Phospholipid depot
12/13/2012US20120316107 Fibrillation-resistant insulin and insulin analogues
12/13/2012US20120315345 Functional food and pharmaceutical compositions for anti-obesity comprising capsanthin and fatty-acyl ester of capsanthin having anti-adipogenic activity
12/13/2012US20120315343 Synchronized water and production and use thereof
12/13/2012US20120315339 Nitrooxy alkanoic acids and derivatives thereof in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
12/13/2012US20120315327 Anti-diabetic composition containing a plant extract of englerina lecardii
12/13/2012US20120315302 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/13/2012US20120315285 Antibody Formulation
12/13/2012US20120315284 Composition for enhancing trail sensitivity comprising inhibitors for expression or activity of tip41 as a target gene of trail sensitizer
12/13/2012US20120315282 Antibodies Specific for TGF-Beta
12/13/2012US20120315274 Methods of Treating Glucose Metabolism Disorders
12/13/2012US20120315258 Bacillus strains and methods for reducing e. coli disease and enhancing performance
12/13/2012US20120315255 Hepatocyte Based Insulin Gene Therapy For Diabetes
12/13/2012US20120315219 Drug Delivery Coating For Use With A Stent
1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 1298